Gerard Anmella , Mireia Primé-Tous , Xavier Segú , Aleix Solanes , Victoria Ruíz , Inés Martín-Villalba , Ivette Morilla , Antonieta Also-Fontanet , Elisenda Sant , Sandra Murgui , Mireia Sans-Corrales , Andrea Murru , Roland Zahn , Allan H. Young , Victor Vicens , Clara Viñas-Bardolet , Juan Francisco Martínez-Cerdá , Jordi Blanch , Joaquim Radua , Miquel-Àngel Fullana , Diego Hidalgo-Mazzei
{"title":"PRimary carE digital Support ToOl in mental health (PRESTO): Design, development and study protocols","authors":"Gerard Anmella , Mireia Primé-Tous , Xavier Segú , Aleix Solanes , Victoria Ruíz , Inés Martín-Villalba , Ivette Morilla , Antonieta Also-Fontanet , Elisenda Sant , Sandra Murgui , Mireia Sans-Corrales , Andrea Murru , Roland Zahn , Allan H. Young , Victor Vicens , Clara Viñas-Bardolet , Juan Francisco Martínez-Cerdá , Jordi Blanch , Joaquim Radua , Miquel-Àngel Fullana , Diego Hidalgo-Mazzei","doi":"10.1016/j.rpsm.2021.04.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p><span>About 30–50% of Primary Care (PC) users in Spain suffer mental health problems, mostly mild to moderate anxious and depressive symptoms, which account for 2% of Spain's total Gross domestic product and 50% of the costs associated to all </span>mental disorders<span>. Mobile health tools have demonstrated to cost-effectively reduce anxious and depressive symptoms while machine learning (ML) techniques have shown to accurately detect severe cases. The main aim of this project is to develop a comprehensive ML digital support platform (PRESTO) to cost-effectively screen, assess, triage, and provide personalized treatments for anxious and depressive symptoms in PC.</span></p></div><div><h3>Methods</h3><p>The project will be carried out in 3 complementary phases: First, a ML predictive severity model will be built based on all the cases referred to the PC mental health support programme during the last 5 years in Catalonia. Simultaneously, a smartphone app to monitor and deliver psychological interventions for anxiety and depressive symptoms will be developed and tested in a clinical trial<span>. Finally, the ML models and the app will be integrated in a comprehensive decision-support platform (PRESTO) which will triage and assign to each patient a specific intervention based on individual personal and clinical characteristics. The effectiveness of PRESTO to reduce waiting times in receiving mental healthcare will be tested in a stepped-wedge cluster randomized controlled trial in 5 PC centres.</span></p></div><div><h3>Discussion</h3><p>PRESTO will offer timely and personalized cost-effective mental health treatment to people with mild to moderate anxious and depressive symptoms. This will result in a reduction of the burden of mental health problems in PC and on society as a whole.</p></div><div><h3>Trial registration</h3><p>The project and their clinical trials were registered in Clinical Trials.gov: <span>NCT04559360</span><svg><path></path></svg> (September 2020).</p></div>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":"17 2","pages":"Pages 114-125"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spanish Journal of Psychiatry and Mental Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1888989121000513","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
About 30–50% of Primary Care (PC) users in Spain suffer mental health problems, mostly mild to moderate anxious and depressive symptoms, which account for 2% of Spain's total Gross domestic product and 50% of the costs associated to all mental disorders. Mobile health tools have demonstrated to cost-effectively reduce anxious and depressive symptoms while machine learning (ML) techniques have shown to accurately detect severe cases. The main aim of this project is to develop a comprehensive ML digital support platform (PRESTO) to cost-effectively screen, assess, triage, and provide personalized treatments for anxious and depressive symptoms in PC.
Methods
The project will be carried out in 3 complementary phases: First, a ML predictive severity model will be built based on all the cases referred to the PC mental health support programme during the last 5 years in Catalonia. Simultaneously, a smartphone app to monitor and deliver psychological interventions for anxiety and depressive symptoms will be developed and tested in a clinical trial. Finally, the ML models and the app will be integrated in a comprehensive decision-support platform (PRESTO) which will triage and assign to each patient a specific intervention based on individual personal and clinical characteristics. The effectiveness of PRESTO to reduce waiting times in receiving mental healthcare will be tested in a stepped-wedge cluster randomized controlled trial in 5 PC centres.
Discussion
PRESTO will offer timely and personalized cost-effective mental health treatment to people with mild to moderate anxious and depressive symptoms. This will result in a reduction of the burden of mental health problems in PC and on society as a whole.
Trial registration
The project and their clinical trials were registered in Clinical Trials.gov: NCT04559360 (September 2020).
背景:在西班牙,约有 30-50% 的初级保健(PC)用户存在心理健康问题,主要是轻度至中度焦虑和抑郁症状,占西班牙国内生产总值的 2%,占所有精神障碍相关费用的 50%。事实证明,移动医疗工具可以经济有效地减少焦虑和抑郁症状,而机器学习(ML)技术则可以准确检测出严重病例。本项目的主要目的是开发一个全面的 ML 数字支持平台(PRESTO),以经济有效的方式筛查、评估、分流 PC 中的焦虑和抑郁症状,并提供个性化治疗:该项目将分三个互补阶段进行:首先,将根据加泰罗尼亚地区过去 5 年中转诊至 PC 心理健康支持计划的所有病例,建立一个 ML 预测严重程度模型。与此同时,还将开发一款智能手机应用程序,用于监测和提供针对焦虑和抑郁症状的心理干预措施,并在临床试验中进行测试。最后,将把 ML 模型和应用程序整合到一个综合决策支持平台(PRESTO)中,该平台将根据个人和临床特征对每位患者进行分流并分配特定的干预措施。PRESTO将在5个PC中心进行阶梯式群组随机对照试验,以检验其在缩短精神医疗服务轮候时间方面的有效性:PRESTO将为有轻度至中度焦虑和抑郁症状的人提供及时和个性化的、具有成本效益的精神健康治疗。讨论:PRESTO 将为有轻度和中度焦虑和抑郁症状的人提供及时、个性化、经济有效的心理健康治疗,从而减轻 PC 患者和整个社会的心理健康问题负担:该项目及其临床试验已在 Clinical Trials.gov 上注册:NCT04559360(2020 年 9 月)。